echoloc/ Companies/ Colossal Biosciences

Company profile

Colossal Biosciences Tech Stack

Genetic engineering company pursuing species de-extinction and conservation

Biotechnology Research Dallas, TX 51–200 employees Founded 2021 Privately Held

Colossal Biosciences applies genome editing to restore extinct species and protect endangered ones, pairing a Benchling and SnapGene lab stack with multi-cloud compute across AWS, GCP and Azure. Research dominates a senior-heavy, accelerating hiring mix, with active work on Hamilton Venus and HighRes Cellario lab automation. Hiring in design, production and entertainment points to an in-house documentary and media operation alongside the science.

Tech Stack 40 technologies

Core StackJavaScript Python C++ AWS PostgreSQL MySQL MongoDB Ruby Java Adobe Premiere Pro Slack Zoom Okta Zscaler DocuSign Hyper-V VBScript GCP Azure Perl SnapGene Benchling Dante BrightSign Adobe Zoom Rooms Red Hat Enterprise Linux Proxmox Meraki Dashboard VLAN+10 more

What Colossal Biosciences Is BuildingChallenges and projects from their job posts

◆Challenges

Analyzing multi-omics data from data-sparse non-model organisms
Optimizing laboratory automation workflows
Establishing a secure, traceable genetic baseline
Standardizing a fitness validation battery
Building clinical systems and scaling veterinary programs
Field collection across outbreak regions

▲Active Projects

Genome editing, reprogramming and lineage differentiation protocols
Delivering edited cell lines for SCNT
Automation methods for Hamilton Venus and HighRes Cellario
Integrating multi-omics datasets
NWS biobanking program
High-impact documentary production

Hiring Activity

Accelerating15 roles · 8 in 30d

Department

Research

Design

Ops

Animal

Engineering

Entertainment

Healthcare

Production

Seniority

Senior

Mid

Junior

Director

Intern

Companies like Colossal Biosciences

100+ Biotechnology Research companies running Python and JavaScript

See the full list

About Colossal Biosciences

Colossal Biosciences is a privately held biotechnology company founded in 2021 and headquartered in Dallas, Texas. It develops genetic engineering technologies aimed at bringing back extinct species, protecting critically endangered animals and repopulating ecosystems, and describes itself as the first to use CRISPR for de-extinction. The company employs 51–200 people and hires in the United States. Its work spans genome editing, cell reprogramming, somatic cell nuclear transfer, animal and veterinary programs, and documentary production.

HeadquartersDallas, TX

Company Size51–200 employees

Founded2021

Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Colossal Biosciences use?

Colossal uses Python, C++, Java and JavaScript, PostgreSQL, MySQL and MongoDB, cloud on AWS, GCP and Azure, plus lab tools Benchling and SnapGene and IT tools like Okta, Zscaler and Red Hat Enterprise Linux.

Is Colossal Biosciences hiring researchers?

Yes. Research is the largest hiring area at Colossal, with hiring accelerating and skewed toward senior roles, alongside openings in design, operations, animal care, engineering and production.

What is Colossal Biosciences working on?

Projects include lab automation on Hamilton Venus and HighRes Cellario, multi-omics data integration, genome editing and reprogramming protocols, edited cell lines for SCNT, a biobanking program and documentary production.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

Deep Origin

Biotechnology Research

Structure Therapeutics

Biotechnology Research

TARGAN Inc.

Biotechnology Research

Kodiak Sciences

Biotechnology Research

How this profile is built

Colossal Biosciences's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.